Skip to content [s] Site map [3] Home [1]
Graphic text

Cancer Research and Foundation News

Cancer Drug Effects Alzheimer's Symptoms in Mice

February 17, 2012

The cancer drug bexarotene quickly eliminates Alzheimer’s disease-associated amyloid beta from the brain and reverses memory problems in mice, a new study finds. The results suggest that bexarotene could help the 5.4 million Americans with Alzheimer’s disease.

Genetic Breakthrough for Brain Cancer in Children

January 30, 2012

An international research team has made a breakthrough that could change the way pediatric cancers are treated in the future. The researchers identified two genetic mutations responsible for up to 40 per cent of glioblastomas in children.

Skin Cancer Drug Approved

January 30, 2012

Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer.

Share this Page

Stay Connected

Button Button Button Button

Get Hope!

Sign up for our newsletter and updates.

CHRISTUS Stehlin Foundation for Cancer Research

10301 Stella Link Road, Suite A
Houston, Texas 77025-5447

Affiliates and Resources

Logo Logo Logo Logo Logo